One of the subtypes is triple-negative breast cancer (TNBC) which is characterized by negative expression for ER, PR, and HER2 (ER-, PR-, and HER2-) and poor patient survival (3). This evidence concerns the gene ERBB2 and triple-negative breast carcinoma.